0
Original Research: COPD |

Drawing Impairment Predicts Mortality in Severe COPD*

Antonelli-Incalzi Raffaele, MD; Corsonello Andrea, MD; Pedone Claudio, MD; Trojano Luigi, MD; Acanfora Domenico, MD; Spada Aldo, MD; Izzo Orsola, PsyD; Rengo Franco, MD
Author and Funding Information

*From Geriatric Medicine (Drs. Antonelli-Incalzi and Pedone), University Campus Bio-Medico, Rome, Italy; the Italian National Research Center on Aging (Dr. Corsonello), Cosenza, Italy; the Department of Psychology (Dr. Trojano), Second University of Naples, Caserta, Italy; Salvatore Maugeri Foundation (Drs. Acanfora and Izzo), Institute of Care and Scientific Research, Rehabilitation Institute of Telese, Benevento, Italy; the San Raffaele Foundation (Dr. Spada), Cittadella della Carità, Taranto, Italy; and Chair of Geriatric Medicine (Dr. Rengo), “Federico II” University School of Medicine, Naples, Italy.

Correspondence to: Andrea Corsonello, MD, Viale della Resistenza Pal Alfa Scala H, I-87036 Rende (CS), Italy; e-mail: andrea_corsonello@tin.it



Chest. 2006;130(6):1687-1694. doi:10.1378/chest.130.6.1687
Text Size: A A A
Published online

Background: Cognitive impairment frequently occurs in elderly COPD patients, but little is known about its prognostic implications. We aimed at evaluating the prognostic role of cognitive impairment in patients with severe COPD.

Methods: Our series consisted of 149 stable patients (mean [± SD] age, 68.7 ± 8.5 years) with COPD and a Pao2 of < 57 mm Hg at rest (n = 97) or at the end of the 6-min walking test (n = 37) who were enrolled in a prospective observational study. After a multidimensional baseline assessment, patients were followed up by telephone calls for a mean duration of 32.5 ± 9.2 months (minimal follow-up duration, 24 months); 134 patients were successfully tracked. We used multivariable Cox proportional hazard analysis to identify predictors of death among clinical/functional variables that previously were shown to have prognostic implications and among neuropsychological indexes selected on the basis of univariate analysis.

Results: We observed 29 deaths over a median follow-up time of 32 months. Only the two following variables were independently associated with the outcome: an abnormal score on the copy with landmark test (hazard ratio [HR], 2.93; 95% confidence interval [CI], 1.34 to 6.39); and a 6-min walk distance of < 300 m (HR, 3.46; 95% CI, 1.15 to 10.5). A Pao2 of < 57 mm Hg at rest (HR, 2.19; 95% CI, 0.93 to 5.18) and an FEV1 of < 40% predicted (HR, 2.74; 95% CI, 0.99 to 7.57) were nearly significantly associated with the outcome, while Paco2, body mass index, physical dependence, comorbid diseases, and the impairment of cognitive domains other than drawing impairment were unrelated to the outcome.

Conclusions: Drawing impairment is a risk factor for mortality and might improve the assessment of hypoxemic COPD patients.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543